Live Research Database
Eczema
Hub: Arlington, TX
Connecting patients in Arlington with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Texas
Available Eczema Opportunities
6 RecruitingNCT06947993(Verify)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT06863961(Verify)
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT06241118(Verify)
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
RECRUITING
Eczema
NCT06389136(Verify)
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RECRUITING
Eczema
NCT06461897(Verify)
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT07298395(Verify)
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RECRUITING
Eczema
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Eczema research in Arlington through safe, transparent, and patient-first clinical trials."
Research Hubs in Arlington
Explore other local breakthroughs
Eczema Hubs in TX
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT